2016-11-30T12:19:16-06:00 2016-03-31 ERNST & YOUNG US LLP 1901 SIXTH AVENUE NORTH SUITE 1200 BIRMINGHAM AL 35203 990 2015-04-01 751835298 SUSAN G KOMEN BREAST CANCER FOUNDATION INC % Robert Green SUSA 9728551600 5005 LBJ Freeway Suite 250 Dallas TX 752446125 ROBERT GREEN CFO 9728551600 2016-11-30 KATHY PITTS P00292940 2052541608 2015 2017-02-10 21:41:12Z SUSAN G KOMEN Robert Green 5005 LBJ Freeway Suite 250 Dallas TX 752446125 205201389 false 7164 X www.komen.org X 1982 TX Komen works to reduce breast cancer deaths by funding research & community-based medical, financial, educational & psychosocial support for those facing breast cancer. 12 11 277 2875 0 77337857 101724559 20910092 18294814 23876364 6101498 -3731604 -3518888 118392709 122601983 45795848 36875933 0 0 24184105 23559800 2905078 2754890 11339035 47479191 41567268 120364222 104757891 -1971513 17844092 240309976 241118651 124648853 106786837 115661123 134331814 X Komen works to reduce breast cancer deaths by funding both research and community-based medical, financial, educational and psychosocial support services for women and men facing breast cancer. false false 41913947 32738690 18432261 GRANTS TO OTHER NON-PROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER RESEARCH PROJECTS, INCLUDING THOSE STUDYING THE BIOLOGY OF BREAST CANCER; EARLY DETECTION, DIAGNOSIS AND PREVENTION STRATEGIES; DEVELOPMENT OF NEW APPROACHES FOR TREATMENT; AND UNDERSTANDING DISPARITIES IN BREAST CANCER OUTCOMES, AS WELL AS RESEARCH RESOURCES AND CONFERENCES. SEE SCHEDULE O FOR ADDITIONAL DETAILS. 33461332 1355502 0 Breast Health programs aimed at increasing the public's knowledge of and access to breast health care including breast self awareness, risk factors, access to early detection, treatment resources for breast cancer patients, and provision of scientifically reviewed research material. This also includes funding for patient navigation programs and resources for health providers. See schedule o for additional details. 5129935 2791741 0 GRANTS TO OTHER NON-PROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER SCREENING, DIAGNOSIS AND TREATMENT PROGRAMS WITH A SPECIAL EMPHASIS ON PATIENT NAVIGATION, ESPECIALLY IN COMMUNITIES WHERE DISPARITIES IN OUTCOMES ARE SIGNIFICANT AND/OR ACCESS IS LIMITED. SEE SCHEDULE O FOR ADDITIONAL DETAILS. 80505214 true true false true false false false false false true true true false false false true false false false false true true false true true false false true false true false false false false false false false false true false false false false false false false false true 139 0 true 277 true false false false false false true true false false false false X 12 11 false false true false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DC FL GA HI IL IN KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X Robert Green 9728551600 5005 LBJ FREEWAY SUITE 250 Dallas TX 752446125 Linda Custard CHAIR OF THE BOARD 1.0 0.0 X X 0 0 0 Connie O'Neill BOD Member & Treasurer 1.0 0.0 X X 0 0 0 Nancy G Brinker BOD Member & Founder 1.0 0.0 X X 261715 0 20372 Jane Abraham BOD Member 1.0 0.0 X 0 0 0 Kaye Ceille BOD Member (Begin 6/24/15) 1.0 0.0 X 0 0 0 Alan D Feld BOD Member 1.0 0.0 X 0 0 0 Janet Dunn Frantz BOD Member (Begin 6/24/15) 1.0 0.0 X 0 0 0 Dan Glennon BOD Member (Begin 6/24/15) 1.0 0.0 X 0 0 0 Melissa Maxfield BOD Member (Begin 6/24/15) 1.0 0.0 X 0 0 0 Dr Olufunmilayo Olopade MD BOD Member 1.0 0.0 X 0 0 0 Meghan Shannon BOD Member (Begin 6/24/15) 1.0 0.0 X 0 0 0 Linda Wilkins BOD Member 1.0 0.0 X 0 0 0 Susie Knopf BOD Member (END 6/24/15) 1.0 0.0 X 0 0 0 Tricia Ory BOD Member (END 6/24/15) 1.0 0.0 X 0 0 0 John DRaffaelli BOD Member (Until 10/20/15) 1.0 0.0 X 0 0 0 Dr Judith Salerno President and CEO 55.0 0.0 X 496324 0 18904 Christina Alford SVP, Development (Beg 7/15) 55.0 0.0 X 142164 0 2584 Robert Green Chief Fin Officer (Beg 4/15) 55.0 0.0 X 158181 0 1623 Lesley Lurie Assistant Secretary 55.0 0.0 X 223930 0 22729 Miguel Perez VP, Affiliate Network 55.0 0.0 X 212270 0 16654 Carrie Walsh SVP Marketing (Beg 9/15) 55.0 0.0 X 102758 0 5681 Ellen Willmott General Counsel and Secretary 55.0 0.0 X 290178 0 24630 Victoria Wolodzko VP Rsrh & Comm. Hlth(beg 6/15) 55.0 0.0 X 188389 0 18586 Norm Bowling Chief Mkt/Rev Off(End 5/22/15) 1.0 0.0 X 178653 0 3829 Eric Montgomery VP, Info Tech (Beg 4/15) 55.0 0.0 X 170775 0 28534 Stephanie Birkey Reffey Managing Dir., Eval & Outcomes 55.0 0.0 X 156449 0 22138 Vanessa Hewitt Managing Dir., Internal Audit 55.0 0.0 X 157520 0 16175 Andrea Rader Managing Director, Comm. 55.0 0.0 X 173314 0 21163 Subhendu Rath Director, IT Enterprise System 55.0 0.0 X 157172 0 27556 Tiffany Tsumpis Senior Attorney 55.0 0.0 X 156479 0 16877 3226271 0 268035 46 false true false Event 360 205 N Michigan Avenue Chicago IL 606015927 Event Management 5095305 Merkle Response Services PO Box 64897 Baltimore MD 21264 Donation Processing 2572266 Possible Worldwide LLC 414 Olive Way Suite 500 Seattle WA 98101 Marketing Services 662399 Ernst Young 3712 Solutions Center Chicago IL 60677 Accounting & Tax SVC 508556 Laurel Strategies Inc 4A Oxford Street Chevy Chase MD 20815 Consulting 480000 20 529644 22674147 78520768 30947600 101724559 Affiliate payments 900099 18294814 18294814 0 0 18294814 2385209 2385209 0 137936 137936 0 0 0 80714759 76998470 3716289 3716289 3716289 1047998 22674147 5179126 -4131128 -4131128 0 222257 421810 -199553 -199553 Shared Services Income 900099 337000 337000 0 0 Other Income 900099 336857 0 0 336857 673857 122601983 18432261 0 2445163 X 33038771 33038771 0 0 3837162 3837162 0 0 2528837 2149511 252884 126442 0 0 0 0 17408013 10961538 5180813 1265662 654542 421319 183550 49673 1778334 1136303 528536 113495 1190074 741820 360581 87673 0 0 0 0 124300 12486 51554 60260 545956 349215 150499 46242 134244 134244 0 0 2754890 2754890 62562 0 62562 0 0 6111989 4202383 298846 1610760 9432818 5448782 269632 3714404 2376158 1829642 285139 261377 0 0 0 0 897434 577043 253997 66394 2085203 1121598 842299 121306 0 0 0 0 1233873 703211 422622 108040 0 0 0 0 0 0 0 0 762943 391865 337656 33422 339193 209899 93553 35741 CONSULTING & PROF. SVCS. 9957496 8636980 1248706 71810 Event Production 3291587 1837564 1199057 254966 Equip Rent & Maint 1429954 587769 594241 247944 Service Fee and Bank Fees 1163749 766483 94694 302572 1617809 1409626 202221 5962 104757891 80505214 12913642 11339035 32443718 18814420 2680009 10949289 0 0 66156825 51130831 28183942 22743789 464293 6498270 0 0 0 0 0 0 292557 187029 2602199 1324958 9470739 7532363 2401142 1938376 122241945 142354264 17941273 14920361 0 0 0 0 25800 20773 240309976 241118651 11874887 9477825 112186111 96670922 587855 638090 0 0 0 0 0 0 0 0 0 0 0 0 124648853 106786837 X 84147622 79473774 31188501 54533040 325000 325000 115661123 134331814 240309976 241118651 X 17844092 -9649023 2091377 0 0 8384245 X X false false false X 159779664 118656952 91606572 77337857 101724559 549105604 0 0 0 0 0 0 159779664 118656952 91606572 77337857 101724559 549105604 10840446 538265158 4528150 4810808 4064746 3542123 2523145 19468972 0 0 0 0 0 0 378313 351342 436740 153632 336857 1656884 570231460 140218777 0.94394 0.95176 X 0.00000 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 2877 66033 131367 152763 134244 218796 91710005 196807418 91844249 197026214 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 144834 98255 91934 218796 553819 250000 250000 250000 250000 1000000 1500000 83839 68694 52478 66033 271044 LOBBYING EXPENSES SCHEDULE C, PART II-A KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO ELIMINATE BREAST CANCER AS A MAJOR HEALTH PROBLEM. 1346721 29808 460 1376069 1346267 4717 4263 1346721 1325000 0 23736 2469 1346267 1325000 0 21 0 21 1325000 1225000 100000 33 0 33 1325000 0.73000 0.27000 false false 0 610067 90380 519687 2533268 2334030 199238 6327404 5107953 1219451 1938376 Long/short equity fund 14920361 F 14920361 0 0 X Intended use of endowment funds SCHEDULE D, PART V, LINE 4 KOMEN HAS THREE PERMANENT ENDOWMENTS: GOODMAN-BRINKER, FIRNBERG, AND A GENERAL ENDOWMENT. THE GOODMAN-BRINKER ENDOWMENT IS FOR BREAST CANCER RESEARCH FELLOWSHIPS; THE FIRNBERG ENDOWMENT IS FOR BREAST CANCER EDUCATIONAL PROGRAMS AND RESEARCH AWARDS; AND THE GENERAL ENDOWMENT'S EARNINGS ARE RESTRICTED FOR ORGANIZATIONAL MISSION ACTIVITIES. FIN 48 (ASC 740) FINANCIAL STATEMENT DISCLOSURE SCHEDULE D, PART X, LINE 2 THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS AT MARCH 31, 2016 OR MARCH 31, 2015. true East Asia and the Pacific 3 Program Services Event Support 72683 South America 2 Program Services EDUC & EVENT SUPPORT 3581 Sub-Saharan Africa 1 Program Services EDUC & EVENT SUPPORT 20000 South Asia 1 Program Services EDUC & EVENT SUPPORT 10773 Russia and the Newly Independent States 1 Send agents to seminar Educ & Event Support 4871 North America 8 Program Services EDUC & EVENT SUPPORT 104015 North America 2 Send agents to seminar 10034 Middle East and North Africa 3 Program Services EDUC & EVENT SUPPORT 86300 Middle East and North Africa 4 Send agents to seminar 16926 Europe (Including Iceland and Greenland) 6 Send agents to seminar 12648 Europe (Including Iceland and Greenland) 12 Program Services EDUC & EVENT SUPPORT 24669 Central America and the Caribbean Grantmaking Education 74750 East Asia and the Pacific Grantmaking Research 151139 Middle East and North Africa Grantmaking Education 217420 Middle East and North Africa Grantmaking Research 200000 North America Grantmaking Research 1241983 South America Grantmaking Education 301593 South America Grantmaking Research 10488 Sub-Saharan Africa Grantmaking Education 25000 Central America and the Caribbean Grantmaking Education 211520 Europe (Including Iceland and Greenland) Grantmaking Research 1403268 43 43 2553385 1650276 4203661 Sub-Saharan Africa EDUCATION 25000 WIRE TRANSFR Middle East and North Africa education 49900 WIRE TRANSFR Central America and the Caribbean Education 53432 WIRE TRANSFR South America EDUCATION 26000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 39922 WIRE TRANSFR Middle East and North Africa Education 50000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 39505 WIRE TRANSFR North America 60000 WIRE TRANSFR South America Education 101030 WIRE TRANSFR Middle East and North Africa 200000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 24000 WIRE TRANSFR Europe (Including Iceland and Greenland) 25000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 200000 WIRE TRANSFR South America education 75000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 420000 WIRE TRANSFR Central America and the Caribbean education 22343 WIRE TRANSFR Central America and the Caribbean Education 18920 WIRE TRANSFR South America Education 24563 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 230184 WIRE TRANSFR Europe (Including Iceland and Greenland) 335000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 34655 WIRE TRANSFR Middle East and North Africa EDUCATION 75500 WIRE TRANSFR North America Research 447011 WIRE TRANSFR Central America and the Caribbean EDUCATION 98124 WIRE TRANSFR Central America and the Caribbean education 18700 WIRE TRANSFR Middle East and North Africa EDUCATION 19020 WIRE TRANSFR East Asia and the Pacific 37580 WIRE TRANSFR North America Research 179600 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 35000 WIRE TRANSFR South America education 75000 WIRE TRANSFR Europe (Including Iceland and Greenland) 20000 WIRE TRANSFR Middle East and North Africa Education 23000 WIRE TRANSFR East Asia and the Pacific research 113558 WIRE TRANSFR Central America and the Caribbean EDUCATION 74750 WIRE TRANSFR North America 555372 WIRE TRANSFR South America 10488 WIRE TRANSFR 36 0 false false false false false false PROCEDURES FOR MONITORING USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATES SCHEDULE F, PART I, LINE 2 AS OUTLINED IN EACH GRANT AGREEMENT, ALL GRANTEES ARE REQUIRED TO SUBMIT, AT A MINIMUM, ONE FINANCIAL AND PROGRESS REPORT WITHIN EACH YEAR OF THE GRANT TERM, AND ANY CHANGE REQUESTS THEY MAY HAVE FOR THEIR PROJECTS. ALL PROGRESS REPORTS AND REQUESTS ARE REVIEWED BY QUALIFIED STAFF. SEE SCHEDULE I, PART IV FOR MORE DETAILS. X X X X X true Merkle Inc Direct Marketing false 18315675 1902692 16412984 Event 360 Fundraising Consulting false 23135659 390691 22744968 Possible Worldwide 414 Olive Way Suite 500 Seattle WA 98101 Marketing Consulting false 281520 Slingshot LLC 208 N Market Street Suite 500 Dallas TX 75202 Fundraising Consulting false 149703 The Pursuant Group 5151 Beltline Road Suite 900 Dallas TX 75254 Fundraising Consulting false 30284 41451334 2754890 39157952 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY 3 day 20438852 19935747 503105 0 973 910855 824416 0 2826737 DC RFTC 1541308 1032128 509180 0 21184 0 11889 580 118788 2 1741985 1706272 35713 0 32954 43588 170014 27628 189520 23722145 22674147 1047998 0 55111 954443 1006319 28208 3135045 5179126 -4131128 NET INCOME SUMMARY SCHEDULE G PART II GROSS RECEIPTS ARE REDUCED BY THE AMOUNT OF CONTRIBUTIONS, PER IRS INSTRUCTIONS. THE CONTRIBUTIONS FOR FISCAL YEAR 2016 WERE $22.7 MILLION. true African Women's Cancer Awareness Assoc 8955 Edmonston Road Greenbelt MD 20770 731704355 501(C)(3) 99201 education Alaska Native Tribal Health Consortium 4000 Ambassador Drive Anchorage AK 99508 920162721 501(C)(3) 62500 screening Albert Einstein College of Med Yeshiva U 1300 Morris Park Ave Bronx NY 104611975 131624225 501(C)(3) 22477 American Association for Cancer Research 615 Chestnut St 17th Fl Philly PA 19106 236251649 501(C)(3) 665000 American Jewish Joint Attn Itai Shamir New York NY 100174014 131656634 501(C)(3) 88703 EDUCATION American Society of Clinical Oncology Conquer Cancer FDN Alexandria VA 22314 136180880 501(C)(3) 500000 research Arlington Free Clinic 2921 11th Street South Arlington VA 22204 541671883 501(C)(3) 99605 screening Baylor College Medicine Grants - Acct Recvbl Houston TX 770303411 741613878 501(C)(3) 1698348 Research Beth Israel Deaconess Medical Center Resrch Fin Office BR109 Boston MA 02215 042103881 501(C)(3) 222000 RESEARCH Boat People SOS 6066 Leesburg Pike 100 FC VA 22041 541563619 501(C)(3) 47178 education Boston University 580 Harrison Avenue 3-W Boston MA 02118 042103547 501(C)(3) 161726 Breast Care for Washington 4 Atlantic St SW Washington DC 20032 455574713 501(C)(3) 100000 Screening Brigham & Women's Hospital PO Box 3149 Boston MA 022413149 042312909 501(C)(3) 343613 Research Broad Institute Inc 415 Main Street Cambridge MA 02142 263428781 501(C)(3) 60000 Burnham Institute for Medical Research Cancer Ctr La Jolla CA 92037 510197108 501(C)(3) 30000 research Bush Global Health Initiative 6116 N Central Expressway Dallas TX 75360 474585630 501(C)(3) 118074 treatment Cancer Care 275 Seventh Avenue New York NY 10001 131825919 501(C)(3) 1493807 treatment Cancer Resource Centers of Mendocino Cty 45040 Calpella Street Mendocino CA 95460 680357416 501(C)(3) 65538 Education Capital Breast Care Center 3970 Reservoir Rd NW Washington DC 20057 530196603 501(C)(3) 50000 education CASA of Maryland Inc Attn Jennifer Freedman Hytvle MD 20783 521372972 501(C)(3) 135382 education Case Western Reserve University Controllers Office Cleveland OH 44106 341018992 501(C)(3) 236563 Children's Hospital Boston Resrch Fin Boston MA 022414413 042774441 501(C)(3) 60000 Research Cincinnati Children's Hospital Medical 3333 Burnet Ave Cincinnati OH 45229 310833936 501(C)(3) 120000 Research Cold Spring Harbor Laboratory Attn Walter Goldschmidts CSH NY 11724 112013303 501(C)(3) 310861 Research Columbia University Medical Center 722 W 168th St 4th Fl New York NY 10027 135598093 501(C)(3) 727831 Research Cornell University 341 Pine Tree Road Ithaca NY 14850 150532082 501(C)(3) 60000 research Dana Farber Cancer Institute 44 Binney St 439C Boston MA 02115 042263040 501(C)(3) 2507556 Doctors Community Hospital 8118 Good Luck Road Lanham MD 207063502 521638026 501(C)(3) 750000 education, screening, and treatment ECOG Research and Education Foundation 1818 Market Street Philadelphia PA 19109 391723095 501(C)(3) 150000 Research Facing Our Risk of Cancer Empowered 16057 TP Blvd W 373 Tampa FL 33647 650927702 501(C)(3) 10000 education Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 19111 232003072 501(C)(3) 120000 Research Fred Hutchinson Cancer Research Center PO Box 19024 J6-330 Seattle WA 98109 563744111 501(C)(3) 231459 Research Friends of Cancer Research Attn Heather S Chaney Wshngtn DC 20036 521983273 501(C)(3) 40000 research George Mason University 4400 Univ Drive MSN 4C6 Fairfax VA 22030 530196584 501(C)(3) 220678 Georgetown University Box 571164 Washington DC 20007 530196603 501(C)(3) 216693 Georgia Health Sciences Univ Rsrch Inst 1120 15th St CJ - 3301 Augusta GA 30912 581418202 501(C)(3) 29204 Research Georgia Regents Research Institute Inc 1120 15th Street Augusta GA 309124810 581418202 501(C)(3) 111919 Research Georgia Tech Research Corporation 505 Tenth Street NW Atlanta GA 30318 580603146 501(C)(3) 150000 Research Global Biological Standards Institute 1020 19th St NW 550 Wshgtn DC 20036 611705421 501(C)(3) 40000 research H Lee Moffitt Cancer Center 12902 Magnolia Drive Tampa FL 33612 592451713 501(C)(3) 60000 Research Harvard University 1350 Massachusetts Avenue Boston MA 02138 042103580 501(C)(3) 512992 education & research Holy Cross Hospital 1500 Forest Glen Rd Silver Spring MD 20910 590791028 501(C)(3) 100000 education Howard University 2041 Georgia Ave NW Wshgtn DC 20059 530204707 501(C)(3) 297503 Education, Screening, and Treatment Hudson-Alpha Institute for Biotechnology 601 Genome Way Huntsville AL 35801 432059317 501(C)(3) 239865 Research Indiana University (Indianapolis) PO Box 66057 Indianapolis IN 462666057 356001673 501(C)(3) 1357075 Research International Scholarship & Tuition Serv 1321 Murfreesboro Road Nashville TN 37217 042697983 501(C)(3) 35000 education Johns Hopkins University 1650 Orleans Street Baltimore MD 21205 520595110 501(C)(3) 697000 Korean Community Svc Ctr of Greater WA 7700 Ltl Rvr Trnpk 406 Annadale VA 22003 386005984 501(C)(3) 100000 education Lawrence Berkeley National Laboratory PO Box 528 Berkeley CA 94701 942951741 501(C)(3) 11857 research Leland Stanford Jr University PO Box 44253 Palo Alto CA 941444253 941156365 501(C)(3) 998842 Research Living Beyond Breast Cancer 354 W Lancaster Ave Haverford PA 19041 530196932 501(C)(3) 102000 Education Lutheran Hospital Association of 106 Blanca Ave Alamosa CO 81101 840255530 501(C)(3) 61692 screening Maasai Wilderness Conservation Fund PO Box 1413 Santa Barbara CA 93102 541943145 501(C)(3) 80040 education Maryland Dept of Health & Mental hygiene 201 W Prstn St 303 Baltimore MD 21201 526002033 501(C)(3) 62425 Screening Mary's Ctr for Maternal&Child Care Inc 2333 Ontario Road NW Washington DC 20009 521594116 501(C)(3) 270000 education, screening, and treatment Massachusetts General Hospital PO Box 414876 Boston MA 02199 042697983 501(C)(3) 516191 Research Mayo Clinic Jacksonville 4500 San Pablo Road Jacksonville FL 32224 593337028 501(C)(3) 39645 research Mayo Clinic Rochester 200 First St SW Rochester MN 559034008 416011702 501(C)(3) 167295 Medical Univeristy of South Carolina 171 Ashley Avenue Charleston SC 29425 576000722 501(C)(3) 60000 research Memorial Sloan-Kettering Cancer Center 633 3rd Ave 28th Fl New York NY 10017 131924236 501(C)(3) 329998 education & research Mercy Medical Ctr 301 St Paul Place Baltimore MD 21202 521495113 501(C)(3) 52768 Metastatic Breast Cancer Network 211 E 18th Street New York City NY 10003 800418281 501(C)(3) 20000 education Metropolitan Chicago Breast Cancer 1645 W Jcksn Blvd 450 Chicago IL 60612 262264895 501(C)(3) 500000 education & Research MidMichigan Medical Center-Gratiot 300 East Warwick Drive Alma MI 48801 381437919 501(C)(3) 99999 education Mobile Medical Care Inc 9309 Old Gergtwn Rd Bethesda MD 20814 237022588 501(C)(3) 294161 Education & screening Mount Sinai School of Medicine 633 Third Avenue New York NY 10017 136171197 501(C)(3) 362000 Research New York University School of Medicine One Park Ave 11th Fl New York NY 10016 135562308 501(C)(3) 198828 research Northwestern University 633 Clark Evanston IL 60208 362167817 501(C)(3) 157640 screening & Research Nueva Vida Inc 2000 P St NW 300 Washington DC 20036 541943145 501(C)(3) 100000 Education Obesity Society 8757 Georgia Avenue Silver Spring MD 20910 541438429 501(C)(3) 7300 Research Oklahoma Medical Research Foundation 825 NE 13th Street Oklahoma City OK 73104 141368361 501(C)(3) 13726 Research Oregon Health & Science University 0690 SW Bancroft Street Portland OR 97239 752668014 501(C)(3) 200000 research Partners for Cancer Care and Prevention 10 E Lee St 1901 Baltimore MD 21202 451605551 501(C)(3) 25000 educaiton Patient Advocate Foundation 421 Butler Farm Road Hampton VA 23666 830292601 501(C)(3) 500000 treatment Prevent Cancer Foundation 1600 Duke Street Alexandria VA 22209 521429544 501(C)(3) 235588 Education & screening Primary Care Coalition-MontgomeryCty Inc 8757 GA Ave 10th Fl Silver Spring MD 20910 521847976 501(C)(3) 250000 Screening & treatment Prince William Hospital 8700 Sudley Road Manassas VA 20110 541307595 501(C)(3) 186235 Education & screening Princeton University 701 Carnegie Center Princeton NJ 08540 210634501 501(C)(3) 111250 research Program for Appropriate PO Box 900922 Seattle WA 98109 911157127 501(C)(3) 72446 education Providence Health Foundation 1150 Varnum Street NE Washington DC 20017 521275583 501(C)(3) 222903 Education/Screening Providence Portland Medical Center 4805 NE Glisan St 5F40 Portland OR 97213 930386906 501(C)(3) 179612 Quantum Leap HealthCare Collaborative 3450 California St SF CA 941181837 204284925 501(C)(3) 70000 Education Regents of University of Michigan 3003 S State St Rm 1054 Ann Arbor MI 48109 746000949 501(C)(3) 160000 Research Research Advocacy Network 6505 West Park Boulevard Plano TX 75093 566001393 501(C)(3) 41537 research Roswell Park Alliance Foundation Elm Carlton Streets Buffalo NY 14263 161391608 501(C)(3) 120000 research Rush University 1700 West Van Buren Chicago IL 60612 362174823 501(C)(3) 14999 research Smith Farm Center for Healing & the Arts 1632 U Street NW Washington DC 20009 590624458 501(C)(3) 500000 education, screening, and treatment St Joseph Medical Center 2500 Bernville Road Reading PA 196030316 530196617 501(C)(3) 86284 education Stanford University PO Box 44253 San Francisco CA 941444253 941156365 501(C)(3) 200000 The Alliance of Pennsylvania Councils 3461 Market Street Camp Hill PA 17011 251888581 501(C)(3) 53408 screening The Ohio State University College 700 Childrens Drive Columbus OH 43205 381746722 501(C)(3) 299915 Research The Red Devils PO Box 36291 Towson MD 21286 743070929 501(C)(3) 34785 treatment The Salk Institute 10010 N Torrey Pines Rd La Jolla CA 92037 376000511 501(C)(3) 240000 Research The University of Chicago 5801 South Ellis Avenue Chicago IL 60637 362177139 501(C)(3) 472000 Thomas Jefferson University 1020 Walnut St Philadelphia PA 19107 232829095 501(C)(3) 295360 Research Trustees of Dartmouth College 11 Rope Ferry Rd HB 6210 Hanover NH 03755 020222111 501(C)(3) 150000 Research Tufts University 800 Washington Street Boston MA 02111 042103634 501(C)(3) 269686 Univ of North Carolina at Chapel Hill 104 Airport Dr 2200 CB 1350 CH NC 27599 566001393 501(C)(3) 2000221 education & Research Univ of TX MD Anderson Cancer Center 1515 Holcombe Blvd Houston TX 77030 746001118 501(C)(3) 1271677 Research University Miami School of Medicine 1400 NW 10th Avenue Miami FL 33136 590624458 501(C)(3) 255951 Research University of Alabama at Birmingham 1530 3rd Ave S Birmingham AL 35294 636005396 501(C)(3) 594618 Research University of California-Berkeley 2195 Hearst Ave Rm130 Berkeley CA 94720 946002123 501(C)(3) 135000 Research University of California-Irvine Biological Sci 3 1400 Irvine CA 92697 952226406 501(C)(3) 40000 Research University of California-Los Angeles 10920 Wilshire Blvd 107 LA CA 90024 956006143 501(C)(3) 240000 Research University of California-San Diego 9500 Gilman Dr La Jolla CA 92093 956006144 501(C)(3) 270000 Research University of California-San Francisco 1600 Divisadero St Box 1710 SF CA 94115 946036493 501(C)(3) 913734 Research University of Cincinnati 51 Gdmn Dr Univ Hall 530 Cincy OH 45221 316000989 501(C)(3) 180000 Research University of Illinois at Chicago 809 S Mrshfld Ave MC551 Chicago IL 60608 376000511 501(C)(3) 190016 research University of Kansas Center for Research 2385 Irving Hill Rd Lawrence KS 66045 480680117 501(C)(3) 60000 Research University of Kansas Medical Center 3901 Rainbow Blvd MSN 1039 KC KS 66160 481108830 501(C)(3) 1697740 Research University of Michigan 3086 Wlvrne Twer Ann Arbor MI 48109 386006309 501(C)(3) 427099 Research University of Minnesota 200 Oak St SE 450 Minneapolis MN 55455 416007513 501(C)(3) 399556 research University of Notre Dame du Lac 731 Grace Hall Notre Dame IL 46556 350868188 501(C)(3) 150000 Research University of Oklahoma Hlth Sci Center 1100 N Lindsay SCB 228 OC OK 73104 736017987 501(C)(3) 38427 Research University of Pennsylvania 3451 Wlnt St P211 Frnkln Philly PA 19104 231352685 501(C)(3) 937985 education & Research University of Pittsburgh 139 Univ Place Pittsburgh PA 152132303 250965591 501(C)(3) 232000 Research University of South Carolina 1600 Hampton St 404H Columbia SC 29208 576001153 501(C)(3) 150000 Research University of Southern California Univ Gardens Bldg LA CA 900898001 951642394 501(C)(3) 712063 Research University of Tennessee 62 South Dunlap Memphis TN 38163 311626179 501(C)(3) 79480 Research University of Texas Health Science Ctr 7703 Floyd Curl Dr MSC 7828 SA TX 78229 741586031 501(C)(3) 39895 research University of Virginia at School of Med PO Box 400195 P211 Frnkln Bldg Chrltsvle VA 22904 237173411 501(C)(3) 32534 research University of Washington 3917 University Way NE Seattle WA 98105 916001537 501(C)(3) 639636 education & research University of Wisconsin - Madison 21 N Park St 6401 Madison WI 53715 396006492 501(C)(3) 179416 research UT Health Center at Tyler 11937 US Highway 271 Tyler TX 757083154 756001354 501(C)(3) 33231 research UT HSC - San Antonio 7703 Floyd Curl Dr SA TX 77229 746002868 501(C)(3) 385000 Research UT Southwestern Medical Center PO Box 841753 Dallas TX 752841753 746000203 501(C)(3) 48000 Research UTMD Anderson Cancer Ctr 1515 Holcombe Blvd 1644 Houston TX 77030 746001118 501(C)(3) 1241902 Research Vanderbilt University Medical Center 3319 W End Ave 100 Nshvle TN 37203 620476822 501(C)(3) 769813 research Vermont Cancer Ctr UVM College of Med 85 S Prospect St Burlington VT 05405 030179440 501(C)(3) 75000 research Vietnamese Resettlement Association Inc 6131 Wlstn Dr Rm 6 FC VA 22044 541512549 501(C)(3) 430224 education, screening, and treatment Virginia Commonwealth University PO Box 843039 Richmond VA 232843038 546001758 501(C)(3) 360000 research Wake Forest University Health Sciences Med CTR Blvd WinstonSalem NC 27157 223849199 501(C)(3) 39592 research Washington Univ at St Louis 700 Rosedale Ave Cmps 1034 SL MO 63112 430653611 501(C)(3) 1565686 research Wayne State University 5057 Woodward Ave 13th Fl Detroit MI 48202 366028429 501(C)(3) 223464 Whitehead Institute 9 Cambridge Center Cambridge MA 021421479 061043412 501(C)(3) 220000 research Widener University One University Place Chester PA 19013 231386178 501(C)(3) 29527 research Young Survival Coalition 61 Broadway Suite 2235 New York NY 10006 134057685 501(c)(3) 10000 education Duke University Medical Center PO Box 602651 Charlotte NC 282602651 560532129 501(C)(3) 1463857 research Univ of Puerto Rico -Recinto de Regular PO Box 365067 San Juan PR 009365067 660433762 501(c)(3) 50000 research UNIVERSITY OF MIAMI SCHOOL OF MEDICINE CTR FOR CNCR PRVNTN GNTCS MIAMI FL 33136 590624458 501(C)(3) 65560 EDUCATION 140 0 Procedures for Monitoring the Use of Grants SCHEDULE I, PART I, LINE 2 SUSAN G. KOMEN'S (KOMEN) POLICIES FOR MANAGING GRANTS FROM THE TIME OF PRE-AWARD THROUGH CLOSEOUT ARE designed TO MAXIMIZE FLEXIBILITY WHILE MAINTAINING A HIGH STANDARD OF ACCOUNTABILITY AND PRESERVING THE INTEGRITY OF THE REVIEW AND AWARD PROCESS. KOMEN REQUIRES ALL GRANTEES TO SIGN A GRANT AGREEMENT SETTING FORTH THE TERMS OF THE GRANT, INCLUDING: PURPOSE, AMOUNT, BUDGETARY RESTRICTIONS, DURATION, PAYMENT SCHEDULE, REPORTING REQUIREMENTS, AUDIT AND EARLY TERMINATION RIGHTS. FOR RESEARCH GRANTS, SCIENTIFIC PROGRESS IS MONITORED THROUGHOUT THE GRANT TERM BY A PH.D. - LEVEL SCIENTIFIC GRANTS MANAGER. FOR EDUCATION, SCREENING, AND TREATMENT GRANTS, PROGRESS IS MONITORED THROUGHOUT THE GRANT TERM BY A MASTERS or PH.D. - LEVEL COMMUNITY OR GLOBAL GRANTS MANAGER. EACH YEAR OF THE GRANT TERM, GRANTEES ARE REQUIRED TO SUBMIT PROGRESS AND FINANCIAL REPORTS DETAILING PROGRESS TOWARD AIMS AND OBJECTIVES, CHALLENGES ENCOUNTERED, AND A FULL ACCOUNTING OF GRANT FUNDS EXPENDED (ACTUAL VERSUS BUDGETED EXPENSES) WITH WRITTEN JUSTIFICATION. AS APPROPRIATE THE GRANTS MANAGER MAY CONDUCT SITE VISITS WITH THE GRANTEE TO BUILD A STRONGER RELATIONSHIP WITH THE GRANTEE; GAIN A BETTER UNDERSTANDING OF THEIR WORK; AND ADDRESS ANY CHALLENGES IMPACTING THE FUNDED PROGRAM. ALL GRANT FUNDS MUST BE EXPENDED IN ACCORDANCE WITH THE PROJECT'S APPROVED BUDGET AND ARE DISBURSED IN ACCORDANCE WITH THE SCHEDULE DOCUMENTED WITHIN THE GRANT AGREEMENT. REQUESTS FOR CHANGES TO THE DESIGN OF THE FUNDED PROJECT OR BUDGET ARE SUBJECT TO PRIOR APPROVAL OF KOMEN IN ACCORDANCE WITH THE TERMS OF THE GRANT AGREEMENT. AS PART OF ITS OVERSIGHT PRACTICES, THE TERMS OF THE GRANT AGREEMENT MAY PROVIDE KOMEN WITH, AMONG OTHER THINGS, THE RIGHT TO REQUEST WITH REASONABLE PRIOR NOTICE TO THE GRANTEE: (1) ADDITIONAL PROGRESS AND/OR FINANCIAL REPORTING FROM THE GRANTEE, (2) GRANTEE PARTICIPATION IN SITE VISITS, TELEPHONE CONFERENCES, PRESENTATIONS, OR OTHER SPEAKING ENGAGEMENTS, AND (3) WITH PRIOR WRITTEN NOTICE, ADJUSTMENT TO THE PROJECT REPORTING PERIOD AND ASSOCIATED DISBURSEMENT OF GRANT FUNDS AT ANY TIME DURING THE GRANT TERM. X true true X X X X X false false false false false false false false false Nancy G Brinker BOD Member & Founder 257778 0 0 0 3937 0 15480 0 4892 0 282087 0 0 0 Dr Judith Salerno President and CEO 491003 0 0 0 5321 0 15346 0 3558 0 515228 0 0 0 Robert Green Chief Fin Officer (Beg 4/15) 155885 0 0 0 2296 0 0 0 1623 0 159804 0 0 0 Lesley Lurie Assistant Secretary 221591 0 0 0 2339 0 10977 0 11752 0 246659 0 0 0 Miguel Perez VP, Affiliate Network 208962 0 0 0 3308 0 8311 0 8343 0 228924 0 0 0 Ellen Willmott General Counsel and Secretary 287268 0 0 0 2910 0 15814 0 8816 0 314808 0 0 0 Victoria Wolodzko VP Rsrh & Comm. Hlth(beg 6/15) 178221 0 7500 0 2668 0 10718 0 7868 0 206975 0 0 0 Norm Bowling Chief Mkt/Rev Off(End 5/22/15) 176683 0 0 0 1970 0 0 0 3829 0 182482 0 0 0 Eric Montgomery VP, Info Tech (Beg 4/15) 168156 0 718 0 1901 0 10909 0 17625 0 199309 0 0 0 Stephanie Birkey Reffey Managing Dir., Eval & Outcomes 154312 0 0 0 2137 0 9726 0 12412 0 178587 0 0 0 Vanessa Hewitt Managing Dir., Internal Audit 157323 0 0 0 197 0 9821 0 6354 0 173695 0 0 0 Andrea Rader Managing Director, Comm. 170093 0 0 0 3221 0 10419 0 10744 0 194477 0 0 0 Subhendu Rath Director, IT Enterprise System 155359 0 0 0 1813 0 9659 0 17897 0 184728 0 0 0 Tiffany Tsumpis Senior Attorney 155513 0 0 0 966 0 9356 0 7521 0 173356 0 0 0 FORM 990, SCHEDULE J, PART I, LINE 1A SUPPLEMENTAL COMPENSATION INFORMATION EXCEPT AS MAY BE APPROVED IN ADVANCE FOR MEDICAL ACCOMODATION, FIRST CLASS AND BUSINESS CLASS FARES FOR DOMESTIC TRAVEL, CANADA, THE CARIBBEAN, CENTRAL AMERICA, AND MEXICO ARE NOT REIMBURSABLE. HOWEVER, PERSONAL FREQUENT FLIER MILEAGE AND/OR COUPONS MAY BE USED FOR NO-COST UPGRADES. IN THE EVENT OF INTERNATIONAL TRAVEL WITH FLIGHT TIMES OF SIX HOURS OR MORE, AND PRE-APPROVAL BUSINESS OR FIRST CLASS TRAVEL MAY BE PERMITTED IF THERE IS A MEDICAL ACCOMODATION OR BUSINESS PURPOSE. WHENEVER POSSIBLE, DISCOUNTED FIRST CLASS AND UPGRADES ARE USED TO MINIMIZE COST. X 1 27000000 IND. 3RD PARTY VALUE X 1 12350 cost or sales price X Aadvantage Miles 131175000 3935250 cost or sales price false true false VOLUNTEERS FORM 990, PART I, QUESTION 6 VOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE SUSAN G. KOMEN 3 DAY SERIES. FORM 990, PART III - PROGRAM SERVICE ACCOMPLISHMENTS SUSAN G. KOMEN IS A LEADING GLOBAL BREAST CANCER ORGANIZATION, FUNDING MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT WHILE PROVIDING REAL TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED MORE THAN $920 MILLION IN BREAST CANCER RESEARCH AND PROVIDED $2 BILLION IN FUNDING FOR PATIENT NAVIGATION, SCREENING, DIAGNOSIS, TREATMENT, EDUCATION, HEALTH SYSTEMS IMPROVEMENT, AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 30 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. RESEARCH SINCE ITS FOUNDING IN 1982, KOMEN'S RESEARCH INVESTMENTS HAVE CONTRIBUTED TO MAJOR ADVANCES IN BREAST CANCER SCIENCE. THE PROGRESS HAS BEEN SIGNIFICANT - TODAY, WE KNOW THAT BREAST CANCER IS MORE THAN A SINGLE DISEASE. WE HAVE A BETTER UNDERSTANDING OF THE GENETICS OF BREAST CANCER AND THE CRITICAL NEED TO TAILOR SCREENING, DIAGNOSIS, TREATMENT AND PREVENTION STRATEGIES TO INDIVIDUALS THROUGH ADVANCES IN PRECISION MEDICINE. KOMEN'S RESEARCH PROGRAMS ARE DESIGNED TO UNDERSTAND THE BIOLOGY OF BREAST CANCER AND ADVANCE THE TRANSLATION OF RESEARCH DISCOVERIES INTO NEW WAYS TO DETECT, DIAGNOSE, TREAT AND PREVENT BREAST CANCER, In order TO REDUCE BREAST CANCER INCIDENCE AND MORTALITY WITHIN THE NEXT DECADE. IN FISCAL YEAR 2016, KOMEN AWARDED OVER 100 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, COLLABORATIONS AND TRAINING IN THE UNITED STATES AND OTHER COUNTRIES, INCLUDING AUSTRALIA, BELGIUM, CANADA, GERMANY, PUERTO RICO, AND THE UNITED KINGDOM. WE CONSIDER IT OUR RESPONSIBILITY TO ENSURE THE CONTINUITY OF BREAST CANCER RESEARCH FOR THE FUTURE. WITH FEDERAL RESEARCH BUDGETS TIGHTENING, WE CANNOT AFFORD TO LOSE PROMISING YOUNG INVESTIGATORS FOR LACK OF FUNDING. TO THAT END, KOMEN AWARDED POSTDOCTORAL FELLOWSHIPS, GRADUATE TRAINING IN DISPARITIES RESEARCH AND CAREER CATALYST RESEARCH GRANTS TO SUPPORT YOUNG INVESTIGATORS IN THE FIELD OF BREAST CANCER RESEARCH. KOMEN'S RESEARCH INVESTMENT THROUGH THE ABOVE GRANT MECHANISMS SUPPORTS PROJECTS THAT AIM TO, AMONG OTHER THINGS: A) DEVELOP TARGETED THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER, B) UNDERSTAND BREAST CANCER PROGRESSION AND METASTASIS, C) PREDICT RISK USING IMAGING, D) REDUCE TOXICITY IN BREAST CANCER RADIOTHERAPY, E) IMPROVE TREATMENT RESPONSE, F) DEVELOP NEW IMAGING TECHNIQUES TO IMPROVE DIAGNOSIS, AND G) UNDERSTAND THE LINK BETWEEN OBESITY AND BREAST CANCER. EACH MECHANISM IS FURTHER DESCRIBED BELOW: POSTDOCTORAL FELLOWSHIPS (PDF): PDF GRANTS SEEK TO ATTRACT AND SUPPORT PROMISING SCIENTISTS EMBARKING ON CAREERS DEDICATED TO BREAST CANCER RESEARCH WHO HAVE NO MORE THAN 3 YEARS POST-COMPLETION OF THEIR MOST RECENT CLINICAL FELLOWSHIP, 5 YEARS POST-COMPLETION OF THEIR MOST RECENT RESIDENCY (FOR PHYSICIANS) OR 5 YEARS POST-COMPLETION OF THEIR MOST RECENT PHD. BY PROVIDING FUNDING TO OUTSTANDING POSTDOCTORAL/POSTGRADUATE FELLOWS UNDER THE GUIDANCE OF A MENTOR, KOMEN SEEKS TO ENSURE THAT A DIVERSE POOL OF HIGHLY TRAINED SCIENTISTS WILL EMERGE AS THE NEXT GENERATION OF LEADERS IN THE FIELD OF BREAST CANCER RESEARCH. PDF GRANTS PROVIDE SUPPORT FOR RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. GRADUATE TRAINING IN DISPARITIES RESEARCH (GTDR): GTDR GRANTS ARE INTENDED TO ESTABLISH AND/OR TO SUSTAIN A TRAINING PROGRAM DEDICATED TO UNDERSTANDING AND ELIMINATING DISPARITIES IN BREAST CANCER OUTCOMES ACROSS POPULATION GROUPS. AT LEAST THREE GRADUATE STUDENTS, PREFERABLY THOSE FROM POPULATIONS AFFECTED BY DISPARITIES IN BREAST CANCER OUTCOMES, ARE SUPPORTED. CAREER CATALYST RESEARCH (CCR): CCR GRANTS PROVIDE UNIQUE OPPORTUNITIES FOR SCIENTISTS WHO HAVE HELD FACULTY POSITIONS FOR NO MORE THAN 6 YEARS AT THE TIME OF FULL APPLICATION TO ACHIEVE RESEARCH INDEPENDENCE. CCR GRANTS PROVIDE SUPPORT FOR HYPOTHESIS-DRIVEN RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. KOMEN ALSO OFFERS RESEARCH GRANTS THAT SUPPORT SPECIAL RESEARCH PROJECTS, PROGRAMS AND COLLABORATIONS THAT LEVERAGE RESEARCH AND COMMUNITY RESOURCES TO FACILITATE THE DEVELOPMENT OF THE INFRASTRUCTURE, TOOLS, AND OTHER MEANS TO ACCELERATE THE TRANSLATION OF SCIENTIFIC DISCOVERIES FROM BENCH TO BEDSIDE TO CURBSIDE. FUNDING FROM ORGANIZATIONS LIKE KOMEN AND ITS SUPPORTERS HAS PROVEN CRITICAL FOR ALL THESE ACTIVITIES, ESPECIALLY AT A TIME OF DIMINISHING FEDERAL FUNDING FOR CANCER RESEARCH AND FOR CLINICAL TRIALS. EXAMPLES OF THESE GRANTS COMMITTED IN FISCAL YEAR 2016 INCLUDE: METASTATIC BREAST CANCER PROJECT: SUPPORT FOR THE METASTATIC BREAST CANCER (MBC) PROJECT WHICH SEEKS TO EMPOWER PATIENTS TO ACCELERATE MBC RESEARCH BY SHARING THEIR SAMPLES AND CLINICAL INFORMATION. THE GOAL IS THAT THIS APPROACH WILL LEAD TO MORE RAPID DISCOVERIES IN METASTATIC BREAST CANCER AND HELP IDENTIFY NEW THERAPEUTIC STRATEGIES. THE PROJECT WORKS BY ASKING PATIENTS WITH METASTATIC BREAST CANCER ACROSS THE COUNTRY TO PARTICIPATE BY SHARING A PORTION OF THEIR STORED TUMOR SAMPLES, A SALIVA SAMPLE, AND COPIES OF THEIR MEDICAL RECORDS. THIS APPROACH ALLOWS PATIENTS WHO DO NOT CURRENTLY HAVE THE OPPORTUNITY TO PARTICIPATE IN RESEARCH THROUGH CLINICAL TRIALS - the vast majority of cancer patients in the U.S. - to say "count me inparticipate in metastatic breast cancer research directly. Within this project, Komen supports the "young patients with metastatic breast cancer" study because breast cancer is the leading cause of cancer-related deaths in women age 40 and younger. YOUNG WOMEN ARE MORE LIKELY TO DEVELOP MORE AGGRESSIVE SUBTYPES OF BREAST CANCER AND SURVIVAL RATES FOR YOUNG WOMEN WITH BREAST CANCER ARE LOWER THAN FOR OLDER WOMEN. THE GOAL OF THIS STUDY IS TO CHARACTERIZE THE TUMOR AND GERMLINE FROM 50-100 YOUNG PATIENTS WITH METASTATIC BREAST CANCER TO BETTER UNDERSTAND THE BIOLOGICAL MECHANISMS FOR THESE AGE DISPARITIES IN BREAST CANCER OUTCOMES. FRIENDS OF CANCER RESEARCH CONFERENCE ON CLINICAL RESEARCH: SUPPORT FOR THE FRIENDS OF CANCER RESEARCH (FOCR) TO CONVENE A CONFERENCE ON CLINICAL CANCER RESEARCH. THIS CONFERENCE ADDRESSES CRITICAL ISSUES IN NEW DRUG DEVELOPMENT AND APPROVAL. THIS EVENT BRINGS TOGETHER APPROXIMATELY 250 LEADERS FROM FEDERAL HEALTH AND REGULATORY AGENCIES, ACADEMIC RESEARCH CENTERS, PATIENT ADVOCACY ORGANIZATIONS AND THE PRIVATE SECTOR TO IDENTIFY CHALLENGES, PROPOSE CONSENSUS SOLUTIONS AND DEVELOP A CLEAR PATH FORWARD ON CRITICAL ISSUES SURROUNDING THE DEVELOPMENT AND REGULATION OF DRUGS AND THERAPIES. THE 2015 CONFERENCE HIGHLIGHTED THE FOLLOWING THREE TOPICS: INTEGRATING ALTERNATIVE MEASURES OF TUMOR RESPONSE INTO DRUG DEVELOPMENT, BLURRING OF PHASE 1, 2 AND 3 TRIALS IN ONCOLOGY (EXPANSION COHORTS IN EARLY DRUG DEVELOPMENT), AND MEASURING PATIENT-REPORTED OUTCOMES IN PRE-MARKET STUDIES. -GLOBAL BIOLOGICAL STANDARDS INSTITUTE TRANING MODULE: SUPPORT TO THE GLOBAL BIOLOGICAL STANDARDS INSTITUTE (GBSI) TO DEVELOP A TRAINING MODULE TO IMPROVE CELL AUTHENTICATION PRACTICE AMONG BREAST CANCER RESEARCHERS. CELL LINES ARE CRITICAL TOOLS IN PRECLINICAL BASIC CANCER RESEARCH BECAUSE THEY ARE THE FOUNDATION FOR FURTHER INVESTIGATION WHICH MAY LEAD TO NEW DIAGNOSTICS AND TREATMENTS. IT IS THEREFORE IMPORTANT FOR RESEARCHERS TO MAKE SURE THAT THE CELLS THEY ARE USING IN THEIR RESEARCH ARE AUTHENTICATED, I.E., THE CELLS ARE WHAT THEY THINK THEY ARE AND ARE FREE OF CONTAMINATION FROM OTHER CELLS OR MICROBES. APPROXIMATELY 15-36% OF RESEARCH INVOLVING CELL LINES USES CELLS THAT ARE CONTAMINATED OR MISIDENTIFIED. THE GBSI WILL DEVELOP A FREELY AVAILABLE, online "active learning" module in cell authentication that equips CANCER RESEARCHERS WITH EXPERT INSTRUCTIONAL VIDEOS, COUPLED WITH A DISSEMINATION CAMPAIGN THAT WILL DECREASE RESEARCH REPRODUCIBILITY PROBLEMS INVOLVING CELL LINES AND IMPROVE RESEARCH PRACTICE. THIS PROJECT WILL ENSURE MORE EFFECTIVE USE OF HUNDREDS OF MILLIONS OF DOLLARS IN RESEARCH EXPENDITURES WHILE SPEEDING THE DEVELOPMENT OF NEW THERAPIES THAT CAN REDUCE THE INCIDENCE AND MORTALITY OF BREAST CANCER. EDUCATION, PATIENT SUPPORT AND PATIENT NAVIGATION KOMEN IS A TRUSTED SOURCE OF BREAST CANCER INFORMATION FOR PEOPLE ALL OVER THE WORLD AND IS INSTRUMENTAL IN CONNECTING PEOPLE WITH THE RESOURCES THEY NEED IN THE FIGHT AGAINST BREAST CANCER. OUR WEBSITE, KOMEN.ORG, PROVIDES CURRENT, SAFE, ACCURATE, COMPREHENSIVE AND UNBIASED INFORMATION ABOUT BREAST CANCER, BASED ON SCIENTIFIC EVIDENCE, AS WELL AS INFORMATION ABOUT OU Significant changes to governing documents FORM 990, PART VI, QUESTION 4 SIGNIFICANT CHANGES DURING FISCAL YEAR 2016: - ESTABLISHED THE MAXIMUM NUMBER OF DIRECTORSHIPS AT 15 - ESTABLISHED A MAXIMUM TOTAL FOR CLASS IV DIRECTORS AT 11 DESCRIBE THE PROCESS USED BY MANAGEMENT &/OR GOVERNING BODY TO REVIEW 990 FORM 990, PART VI, QUESTION 11B MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVELS OF MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS REVIEWS AND MAKES AN APPROVAL RECOMMENDATION REGARDING THE FORM 990 TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS APPROVES THE FORM 990 PRIOR TO THE FORM BEING FILED. DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICTS OF INTEREST FORM 990, PART VI, QUESTION 12C KOMEN PRODUCES AN ANNUAL SURVEY REQUIRING ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS, AND ADVISORY BOARDS TO DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST THEY MAY HAVE. ANY CONFLICTS ARE THEN REVIEWED BY MANAGEMENT AND THE AUDIT COMMITTEE AND APPROPRIATE MEASURES ARE TAKEN. ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS AND ADVISORY BOARDS ARE REQUIRED TO UPDATE THEIR CONFLICT OF INTEREST DISCLOSURES AS NECESSARY DURING THE YEAR. OFFICES & POSITIONS FOR WHICH PROCESS WAS USED, & YEAR PROCESS WAS BEGUN FORM 990, PART VI, QUESTIONS 15A AND 15B THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE PRESIDENT/CHIEF EXECUTIVE OFFICER; THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER EMPLOYEES; GRANTING THE CEO AUTHORITY TO DETERMINE ACTUAL COMPENSATION LEVELS WITHIN AN APPROVED RANGE; AND INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. FOR THE POSITION OF PRESIDENT/CEO, EXTERNAL BENCHMARKING WAS CONDUCTED TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION. AVAIL OF GOV DOCS, CONFLICT OF INTEREST POLICY, & FIN STMTS TO GEN PUBLIC FORM 990, PART VI, QUESTION 19 KOMEN'S FINANCIAL STATEMENTS AND THE FORM 990 ARE PUBLICLY AVAILABLE ON OUR WEBSITE. THE CERTIFICATE OF FORMATION IS AVAILABLE FROM THE TEXAS SECRETARY OF STATE, AND OTHER GOVERNING DOCUMENTS ARE MADE AVAILABLE AS REQUIRED BY STATE LAW. FORM 1023 AND THE CONFLICT OF INTEREST POLICY ARE NOT ONLINE BUT ARE AVAILABLE TO THE PUBLIC UPON REQUEST. ADDITNL DETAIL ON EVENT PRODUCTION EXPENSES INCLUDED on other exp FORM 990, PART IX, LINE 24 Komen pays 80% of the cost of all T-shirts for the Susan G. Komen Race for the Cure events conducted by the Komen Affiliates during the year. OTHER CHANGES IN NET ASSETS OR FUND BALANCES FORM 990, PART XI, LINE 9 Rescinded Grants $8,384,244 Rounding $1 ---------- Total $8,384,245 ==========